about
Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertilityGenetic variation in the progesterone receptor gene and ovarian cancer risk.GADD45 proteins: central players in tumorigenesisEffects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysisEvidence for colorectal cancer cell specificity of aspirin effects on NF kappa B signalling and apoptosisRisk of breast cancer among users of aspirin and other anti-inflammatory drugsDo nonsteroidal anti-inflammatory drugs affect the risk of developing ovarian cancer? A meta-analysisCancer risk in persons receiving prescriptions for paracetamol: a Danish cohort studyRisk of cancer in a large cohort of nonaspirin NSAID users: a population-based studyAnalgesic medication use and risk of epithelial ovarian cancer in African American women.Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches.Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health StudyAnalgesic use and sex steroid hormone concentrations in postmenopausal women.Epidemiological and genetic factors associated with ovarian cancer.Ovarian cancer: epidemiology, biology, and prognostic factors.Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy.Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia.C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy).Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer riskMarkers of inflammation and risk of ovarian cancer in Los Angeles CountyPooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma riskPathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implicationsCombined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian carcinoma in vivo.Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer riskModulation of inflammatory signaling pathways by phytochemicals in ovarian cancerIs acetaminophen, and its combination with pamabrom, an effective therapeutic option in primary dysmenorrhoea?Ovarian cancer risk in relation to medical visits, pelvic examinations and type of health care provider.A reduction of cyclooxygenase 2 gene dosage counters the ovarian morphological aging and tumor phenotype in Wv mice.Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinomaParacetamol use and risk of ovarian cancer: a meta-analysisReview of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the Multiethnic Cohort.Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancerAspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection.Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review.IKK inhibition increases bortezomib effectiveness in ovarian cancer.Meta-analysis on the association between non-steroidal anti-inflammatory drug use and ovarian cancer.Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival.Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity.Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers.
P2860
Q24200437-EAEC61A4-85EE-4928-8F3C-2B93D33592ABQ24540482-06B29107-4285-48D3-89F9-0908CFDBBBE8Q24608649-8AF8B061-B6C5-4F10-8215-135407B7C034Q24796323-E5D306C4-E9DB-4661-B6F9-5D7300EB57AFQ28168893-0628306C-160B-47D9-AAF8-0A3F6EEF390BQ28169157-AD173C0A-6151-4E66-88F3-5F95763500C9Q28185207-23C2DFF7-18C0-418E-847F-DED4D0468BDEQ28192013-74D701F1-3DEC-4312-93A7-B57DC516021FQ28196301-711A8008-BF6C-4521-8A14-6CF16B2B131EQ30277284-79138FB9-ABCB-4E3B-A630-C1A1B2B72265Q32052639-017B2546-F697-4520-8B01-6172E8864DF1Q33645700-F218D397-E0B6-4B6E-82EE-3CC127CC57B2Q33780860-996C3139-4328-4070-AB66-D02FBBFB364BQ33936537-E69A5415-812D-40DC-8DB4-D3E0A954351DQ33959805-A3F310DB-91AE-4BCB-932C-C355B10114D2Q34023344-CE92DDC8-F6A3-4E30-85A7-5C15035034D6Q34082384-2CF7754B-3333-49BB-BDB5-900D298E90FBQ34304775-DC7FDAEC-FEBC-43D5-81E5-A47B7B4575B2Q34345107-29D79BEC-941C-44CB-9CAA-280198ABC482Q34372351-ADC6E036-AB0C-4BE6-878B-D15ABA610B0FQ34453715-34D81A79-4A40-49C9-8829-F55C4713AFEAQ34501822-A7708512-A18E-48B1-9D27-4B239720E174Q34578154-D33D50E6-541E-497B-A1EB-48506DE54F92Q34794017-9FCAC239-BEFC-458C-B2DF-D773AABF63AFQ34975827-C0D299E0-BFEB-44D0-BA5A-822CE63FBBE1Q35688164-0C467C47-A283-446E-A7B7-843E9F3D4E6AQ35688551-EE8AFD86-1954-4ED2-863B-0AE358C17301Q35691626-FBCF5E89-F432-40BD-BEAF-0C94D779530AQ35788745-1976C8CE-7DF4-476E-AFB7-C9671F044977Q35827624-6145B347-8F32-40B8-A85A-B32B16E8D70FQ35865198-8300F67A-B5E4-44A8-ADAD-AE4AB4A307C3Q36218488-6A7FF904-7364-4A0C-9E6F-C5FF30DD4D0DQ36266504-08596928-C7BF-496B-8397-7DE1D1719230Q36309767-A50044C8-D26E-49A3-8D3C-9ED04E70BA75Q36313004-3F79B1BD-CDB7-4BEB-A753-196C9B98989BQ36413454-A07ED9C1-5470-40BB-A49F-F19344C299C0Q36562438-8EE45837-786D-486C-9A0F-2EDBD8BD7EA4Q36640332-34651004-E574-43C2-A292-AD3C66A51D0FQ36696528-1BC5C13D-EDD9-4E3D-9051-2AF9EFC0DE33Q36874434-35D3A126-D3E1-4E92-8101-705CB4D8886F
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Over-the-counter analgesics and risk of ovarian cancer.
@en
Over-the-counter analgesics and risk of ovarian cancer.
@nl
type
label
Over-the-counter analgesics and risk of ovarian cancer.
@en
Over-the-counter analgesics and risk of ovarian cancer.
@nl
prefLabel
Over-the-counter analgesics and risk of ovarian cancer.
@en
Over-the-counter analgesics and risk of ovarian cancer.
@nl
P2093
P1433
P1476
Over-the-counter analgesics and risk of ovarian cancer.
@en
P2093
B L Harlow
D W Cramer
E R Greenberg
L Titus-Ernstoff
P304
P356
10.1016/S0140-6736(97)08064-1
P407
P577
1998-01-01T00:00:00Z